Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-079913
Filing Date
2025-08-22
Accepted
2025-08-22 16:15:10
Documents
10
Period of Report
2025-08-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0253963-6k_akanda.htm 6-K 32504
2 AMENDMENT #2 TO SHARE EXCHANGE AGREEMENT DATED AS OF AUGUST 19, 2025 ea025396301ex10-1_akanda.htm EX-10.1 66457
3 REGISTRATION RIGHTS AGREEMENT DATED AUGUST 19, 2025 ea025396301ex10-2_akanda.htm EX-10.2 137799
4 DEBT SETTLEMENT AGREEMENT WITH PGC FINCO INC ea025396301ex10-3_akanda.htm EX-10.3 86590
5 DEBT SETTLEMENT AGREEMENT WITH DUNSTAN HOLDINGS LTD ea025396301ex10-4_akanda.htm EX-10.4 86794
6 CONVERTIBLE PROMISSORY NOTE WITH PGC FINCO INC ea025396301ex10-5_akanda.htm EX-10.5 56502
7 CONVERTIBLE PROMISSORY NOTE WITH DUNSTAN HOLDINGS LTD ea025396301ex10-6_akanda.htm EX-10.6 56464
8 PROMISSORY NOTE WITH 1353744 B.C. LTD ea025396301ex10-7_akanda.htm EX-10.7 62301
9 GENERAL SECURITY AGREEMENT IN FAVOR OF 1353744 B.C. LTD ea025396301ex10-8_akanda.htm EX-10.8 54260
10 PRESS RELEASE DATED AUGUST 20, 2025 ea025396301ex99-1_akanda.htm EX-99.1 11580
  Complete submission text file 0001213900-25-079913.txt   652320
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 251246425
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)